Throughout Election Day and night, CBS News' Confirmed team will be fact checking reports of threats around voting today, voter fraud, election hacking, and more as the nation votes and waits to ...

Full fact check: Sign with swastika 'absolutely not' from Trump campaign, GOP official says There is no evidence Rogan made such a statement against Trump. This was further confirmed late on Nov ...

Over the last month, Lisa Desjardins and Deema Zein have been counting down to November 5 with Election Day facts Well, it's been a long road to this Election Day, and our incredible digital team ...

The biotech chose to add a second candidate in April when it inked a $1.8 billion deal to buy ProfoundBio for a rival to AbbVie’s Elahere. It had a third asset thrust into its hands in August ...

Conservatives and social media commentators began sharing claims on election night that Google had been projecting a pro-Kamala Harris bias, alleging results mapped where voters could cast their ...

Additionally, Ms. White helped to maximize the successful commercial launch of ELAHERE®, a first-in-class antibody-drug ... this press release that do not relate to matters of historical fact should ...

When you buy through our links, Business Insider may earn an affiliate commission. Learn more The best sheets can make your bed a cozy, dreamy oasis that you look forward to falling into each ...

Getty Images / Pekic A company's financial statements—balance sheet, income, and cash flow statements—are a key source of data for analyzing the investment value of its stock. Stock investors ...

They don’t tent up as much as the Quince sheets, but they’re still quite crisp and cool, and I slept comfortably in them over the summer. Trapskin appreciates the fact the cotton is not ...

Health misinformation can ruin lives and damage health services. Our health team fact checks claims about health including funding and delivery, and dangerous medical claims, and makes recommendations ...

It’s worth noting that BMS’ decision to exit the deal comes shortly after AbbVie secured full FDA approval for its FRα-directed ADC candidate – Elahere (mirvetuximab soravtansine ...